Attached files
| file | filename |
|---|---|
| EX-99.1 - STAAR SURGICAL CO | v214747_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of Earliest Event Reported):
|
March 9, 2011
|
STAAR Surgical Company
(Exact name of registrant as specified in its charter)
|
Delaware
|
0-11634
|
95-3797439
|
|
_____________________
(State or other jurisdiction
|
_____________
(Commission
|
______________
(I.R.S. Employer
|
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
|
||
|
1911 Walker Ave, Monrovia, California
|
91016
|
|
|
_________________________________
(Address of principal executive offices)
|
___________
(Zip Code)
|
|
Registrant’s telephone number, including area code:
|
626-303-7902
|
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation FD Disclosure.
On March 9, 2011, the Company filed a press release regarding its distribution agreement with Ellex Australia Pty Ltd. A copy of the press release is furnished as Exhibit 99.1to this report and is incorporated herein by this reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
March 15, 2011
|
STAAR Surgical Company
By: /s/ Barry Caldwell
Barry Caldwell
President and Chief Executive Officer
|
Exhibit Index
Exhibit No. Description
99.1 Press release of the Company dated March 9, 2011.